MiR-205 regulates basement membrane deposition in human prostate: Implications for cancer development

Cell Death and Differentiation

Volumn 19, Issue 11, 2012, Pages 1750-1760

  Gandellini, P ^a   Profumo, V ^a   Casamichele, A ^a   Fenderico, N ^a   Borrelli, S ^b   Petrovich, G ^b   Santilli, G ^a   Callari, M ^a   Colecchia, M ^a   Pozzi, S ^b   De Cesare, M ^a   Folini, M ^a   Valdagni, R ^a   Mantovani, R ^b   Zaffaroni, N ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

3D culture; basal layer of epithelium; basement membrane; microRNA; p63; prostate cancer

Indexed keywords

BETA4 INTEGRIN; DELTA NP63 ALPHA; KALININ; MEMBRANE PROTEIN; MICRORNA 205; PROTEASOME; UNCLASSIFIED DRUG;

ACINAR CELL; ARTICLE; BASEMENT MEMBRANE; CANCER CELL; CARCINOGENESIS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN DEGRADATION; PROTEIN INTERACTION;

BASEMENT MEMBRANE; CELL ADHESION MOLECULES; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; INTEGRIN BETA4; MALE; MICRORNAS; PROMOTER REGIONS, GENETIC; PROSTATE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 84871003536     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2012.56     Document Type: Article

References (39)

1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
2. Gandellini P, Profumo V, Folini M, Zaffaroni N. MicroRNAs as new therapeutic targets and tools in cancer. Expert Opin Ther Targets 2011; 15: 265-279.
3. Gandellini P, Folini M, Longoni N, Pennati M, Binda M, Colecchia M, et al. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Res 2009; 69: 2287-2295.
4. Gandellini P, Folini M, Zaffaroni N. Towards the definition of prostate cancer-related microRNAs: where are we now? Trends Mol Med 2009; 15: 381-390.
5. Schaefer A, Stephan C, Busch J, Yousef GM, Jung K. Diagnostic, prognostic and therapeutic implications of microRNAs in urologictumors. Nat Rev Urol 2010; 7:286-297.
6. Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, et al. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 2010; 126: 1166-1176.
7. Signoretti S, Loda M. Defining cell lineages in the prostate epithelium. Cell Cycle 2006; 5: 138-141.
8. Zhang L, Zhao W, Valdez JM, Creighton CJ, Xin L. Low-density Taqman miRNA array reveals miRNAs differentially expressed in prostatic stem cells and luminal cells. Prostate 2010; 70: 297-304.
9. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601.
10. Grisanzio C, Signoretti S. p63 in prostate biology and pathology. J Cell Biochem 2008; 103: 1354-1368.
11. Weinstein MH, Signoretti S, Loda M. Diagnostic utilityof immunohistochemical stainingfor p63, a sensitive marker of prostatic basal cells. Mod Pathol 2002; 15:1302-1308.
12. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 2008; 68: 6162-6170.
13. Bello D, Webber MM, Kleinman HK, Wartinger DD, Rhim JS. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis 1997; 18:1215-1223.
14. Martynova E, Pozzi S, Basile V, Dolfini D, Zambelli F, Imbriano C, et al. Gain-of-function p53 mutants have widespread genomic locations partially overlapping with p63. Oncotarget 2012; 3: 132-143.
15. Yu J, Peng H, Ruan Q, Fatima A, Getsios S, Lavker RM. MicroRNA-205 promotes keratinocyte migration viathe lipid phosphatase SHIP2. FASEB J2010; 24: 3950-3959.
16. Bhatnagar N, Li X, Padi SK, Zhang Q, Tang MS, Guo B. Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells. Cell Death Dis 2010; 1: e105.
17. Yu X, Lin J, Zack DJ, Mendell JT, Qian J. Analysis of regulatory network topology reveals functionally distinct classes of microRNAs. Nucleic Acids Res 2008; 36: 6494-6503.
18. Vandewalle C, Van Roy F, Berx G. The role of the ZEB family of transcription factors in development and disease. Cell Mol Life Sci 2009; 66: 773-787.
19. Fontemaggi G, Gurtner A, Damalas A, Costanzo A, Higashi Y, Sacchi A, et al. DeltaEF1 repressor controls selectively p53 family members during differentiation. Oncogene 2005; 24: 7273-7280.
20. Patrick BA, Gong X, Jaiswal AK. Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer. Oncogene 2011; 67:1098-1107.
21. LeBleu VS, Macdonald B, Kalluri R. Structure and function of basement membranes. Exp Biol Med 2007; 232:1121-1129.
22. Guess CM, Quaranta V. Defining the role of laminin-332 in carcinoma. Matrix Biol 2009; 28: 445-455.
23. Drake JM, Barnes JM, Madsen JM, Domann FE, Stipp CS, Henry MD. ZEB1 coordinately regulates laminin-332 and β4 integrin expression altering the invasive phenotype of prostate cancer cells. J Biol Chem 2010; 285: 33940-33948.
24. Spaderna S, Schmalhofer O, Hlubek F, Berx G, Eger A, Merkel S, et al. A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 2006;131: 830-840.
25. Ke XS, Qu Y, Rostad K, Li WC, Lin B, Halvorsen OJ, et al. Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. PLoS One 2009; 4: e 4687.
26. Carroll DK, Carroll JS, Leong CO, Cheng F, Brown M, Mills AA, et al. p63 Regulates an adhesion programme and cell survival in epithelial cells. Nat Cell Biol 2006; 8: 551-561.
27. Härmä V, Virtanen J, Mäkelä R, Happonen A, Mpindi JP, Knuuttila M, et al. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS One 2010; 5: e 10431.
28. Signoretti S, Pires MM, Lindauer M, Horner JW, Grisanzio C, Dhar S, et al. p63 Regulates commitment to the prostate cell lineage. Proc Natl Acad Sci USA 2005; 102: 11355-11360.
29. Koster MI, Dai D, Marinari B, Sano Y, Costanzo A, Karin M, et al. p63 induces key target genes required for epidermal morphogenesis. Proc Natl Acad Sci USA 2007; 104: 3255-3260.
30. Kurata S, Okuyama T, Osada M, Watanabe T, Tomimori Y, Sato S, et al. p51/p63 Controls subunit alpha3 of the major epidermis integrin anchoring the stem cells to the niche. J Biol Chem 2004; 279: 50069-50077.
31. Liu A, Wei L, Gardner WA, Deng CX, Man YG. Correlated alterations in prostate basal cell layer and basement membrane. Int J Biol Sci 2009; 5: 276-285.
32. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, Schwartz G, et al. Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 2007; 67:11612-11620.
33. Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, et al. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol 2009; 27: 2030-2037.
34. Taylor RA, Toivanen R, Risbridger GP. Stem cells in prostate cancer: treating the root of the problem. Endocr Relat Cancer 2010; 17: R273-R285.
35. Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, Witte ON. Basalepithelialstem cells are efficient targets for prostate cancer initiation. Proc Natl Acad Sci USA 2010; 107: 2610-2615.
36. Wang F, Hansen RK, Radisky D, Yoneda T, Barcellos-Hoff MH, Petersen OW, et al. Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J Natl Cancer Inst 2002; 94:1494-1503.
37. Testa A, Donati G, Yan P, Romani F, Huang TH, Viganò MA, et al. Chromatin immunoprecipitation (ChIP) on chip experiments uncover a widespread distribution of NF-Y binding CCAAT sites outside of core promoters. J Biol Chem 2005; 280:13606-13615.
38. Ortt K, Sinha S. Derivation of the consensus DNA-binding sequence for p63 reveals unique requirements that are distinct from p53. FEBS Lett 2006; 580: 4544-4550.
39. Tyson DR, Inokuchi J, Tsunoda T, Lau A, Ornstein DK. Culture requirements of prostatic epithelial cell lines for acinar morphogenesis and lumen formation in vitro: role of extracellular calcium. Prostate 2007; 67:1601-1613.